Methodological issues in a study of long-term maintenance therapy with quetiapine versus haloperidol decanoate.
Adetunji
Babatunde
B
Basil
Biju
B
Mathews
Maju
M
Williams
Adedapo
A
Osinowo
Thomas
T
D000284:Administration, Oral; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003987:Dibenzothiazepines / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006220:Haloperidol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007267:Injections; D011618:Psychotic Disorders / Q000188:drug therapy / Q000517:prevention & control; D000069348:Quetiapine Fumarate; D012107:Research Design / Q000592:standards; D018401:Sample Size; D012559:Schizophrenia / Q000188:drug therapy / Q000517:prevention & control*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate; C033563:haloperidol decanoate; D006220:Haloperidol